Survival differences in advanced gynecological cancers after the development of immune checkpoint inhibitors and targeted therapy: United States SEER-based population study.
Year: 2026
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Institutions: University of Alabama at Birmingham, UAB Medicine
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162680994
FWCI:
Cites:
Cited by:
Related to:
